NCT07836114 · NOT YET RECRUITING

Virtual Outreach and Individualized Coaching Extension

This study tests whether a nurse-led program using a voice-controlled smart speaker with a screen, placed in the home, helps older adults with mild memory problems manage their chronic health conditions. It also looks at what nursing time and clinic resources the program would need. Phase is not applicable because this is a care-delivery study, not a drug trial.

You may qualify if

  • Age 65 years or older
  • Two or more chronic conditions
  • Mild cognitive impairment, defined as a Montreal Cognitive Assessment Blind (MoCA-Blind) score of 13 to 17, with no diagnosis of Alzheimer's disease or a related dementia
  • Living independently in a community-based setting (not residing in a nursing home or in assisted living with skilled nursing support)
  • Able to speak, read, and understand English
  • Able to provide informed consent for themselves, as confirmed at the time of consent
  • Home environment able to accommodate the study devices, including electrical power and a suitable location for an Echo Show
  • Willing and able to engage in a technology-based intervention, as indicated by a Yes response to an engagement-readiness item administered during screening

You're excluded if

  • Diagnosis of Alzheimer's disease or a related dementia
  • Adults unable to consent for themselves
  • Individuals who are not able to clearly understand English
  • Severe uncorrected hearing or vision impairment that would prevent interaction with a voice-activated device with a screen
  • Planned relocation or absence from the home for an extended period during the 12-week study period
  • Concurrent enrollment in another intervention study addressing chronic disease self-management
  • Any medical, psychiatric, or social circumstance that, in the judgment of the study team, would prevent safe participation or completion of study procedures

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-09-23

View full record on ClinicalTrials.gov

All APOE4 clinical trials